Life Science Leader

Life Science Leader is a key member of the Life Science Connect media group. The goal of Life Science Connect is to create connections and encourage partnerships in the development of pharmaceuticals and medical devices, ultimately working to bring more life-saving and life-enhancing treatments to the market. The Life Science Connect media group includes a variety of industry websites, the monthly magazine Life Science Leader, conferences focused on the pharmaceutical sector, and the Life Science Training Institute.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1767610

United States

#669184

Health/Biotechnology and Pharmaceuticals

#573

Traffic sources

Monthly visitors

Articles

BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies

1 week ago | lifescienceleader.com | Ben Comer

By Ben Comer, Chief Editor, Life Science Leader The annual BIO International Convention, held this year in Boston on June 16 through 19, is a choose-your-own-adventure kind of meeting.
Companies To Watch: Vivani Medical

1 month ago | lifescienceleader.com | Ben Comer

By Ben Comer, Chief Editor, Life Science Leader Overcoming adherence and tolerability issues in obesity and diabetes treatment. Snapshot Vivani’s subdermal implant NanoPortal device, a platform drug delivery technology, is designed to deliver a near-constant and minimally fluctuating dose of an active pharmaceutical drug for a duration of six months, and potentially one year.
Promoting A Newly Approved Indication Against Established Competitors

1 month ago | lifescienceleader.com | Ben Comer

By Ben Comer, Chief Editor, Life Science Leader There are lots of reasons why physicians and patients (and payers) might prefer one drug over another for the treatment of a given disease. Efficacy and safety are paramount, of course, but there are other factors, including drug price (and rebates), administration method, drug mechanism, an individual’s unique patient profile and history, as well as personal preferences for specific drug benefits or safety risks, compared with others.
Building Uniquity Bio: Teams, Capital, And Strategy

2 months ago | lifescienceleader.com | Ben Comer

By Ben Comer, Chief Editor, Life Science Leader On a recent episode of the Business of Biotech podcast, Brian Lortie, president and CEO of Uniquity Bio, offered up useful advice about the complex process of building and leading a biotech startup in today's uncertain and evolving landscape.
Amgen's Ian Thompson On Leadership And A Global Mindset

2 months ago | lifescienceleader.com | Ben Comer

By Ben Comer, Chief Editor, Life Science Leader Riding for the British Cycling team was a foundational experience for Ian Thompson, SVP and general manager of U.S. business operations at Amgen. During a recent conversation about his 16-year tenure at Amgen, and what the future holds for one of biotech’s biggest success stories, Thompson consistently tied his approach to management and business strategy to lessons learned from cycling — uphill and down.
Companies To Watch: Imunon

Mar 31, 2025 | lifescienceleader.com | Ben Comer

Article | March 31, 2025 Source: Life Science Leader By Ben Comer, Chief Editor, Life Science Leader Using targeted therapy to transform the standard of care in advanced ovarian cancer Snapshot With the recent sign-off from the FDA on protocols for a pivotal Phase 3 trial of IMNN-001 in advanced ovarian cancer, Imunon is poised to bring its IL-12 DNA plasmid vector (encased in a nanoparticle delivery system) into late-stage clinical trials.
How To Get Ready For The Talent Migration Between Pharma And Biotech

Mar 25, 2025 | lifescienceleader.com | David Ford |John Archer

Guest Column | March 25, 2025 By David Ford and John Archer The life sciences industry is on the brink of a significant shift. Over the next few years, a historic patent cliff will reshape Big Pharma's landscape, triggering waves of talent movement between pharmaceutical and biotech companies. The last time the industry faced a similar challenge was in the early 2010s.
Pharma's Guide To Making Health Communications Land Well

Mar 11, 2025 | lifescienceleader.com

New treatment paradigms are making biopharma industry stakeholder communications more ambitious and complex. But they must also be credible and...
A Guide To Successful Product Launches For Small And Midsized Biotechs

Mar 3, 2025 | lifescienceleader.com

Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate the complexities of a...
A CEO With A General Counsel's Perspective

Feb 28, 2025 | lifescienceleader.com | Ben Comer

By Ben Comer, Chief Editor, Life Science Leader Should aspiring biopharmaceutical leaders focus on deep specialization and expertise in a singular area, or seek new and variable experiences across different parts of the business, developing a versatile skillset that can plug and play into leadership roles as needed?